Drug Type Small molecule drug |
Synonyms BMS 986120, UDM-002985 |
Target |
Mechanism PAR-4 antagonists(Protease-activated receptor-4 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H23N5O5S2 |
InChIKeyMINMDCMSHDBHKG-UHFFFAOYSA-N |
CAS Registry1478712-37-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thrombosis | Phase 2 | US | - |
Phase 1 | - | 24 | pegdegvjiv(pdgleyjtzr) = mcqcbpnqou nvlgssoubm (wgolstdrjm ) View more | - | 26 Jun 2022 | ||
Phase 1 | 40 | lalacetniq(tldrrzjgms) = bxhzvlzpxq wkamwyumqx (bihqcqknsd, 19.3 ~ 47.3) View more | Positive | 01 Feb 2018 | |||
- |